George Coukos

65.1k citations

396 papers · 35.5k indexed · 19 hit papers · h-index 87

Immunology top 0.02%
- Immunotherapy and Immune Responses 124
- Immune Cell Function and Interaction 69
- T-cell and B-cell Immunology 35
Oncology top 0.02%
- Cancer Immunotherapy and Biomarkers 86
- CAR-T cell therapy research 77
Cancer Research top 0.1%
Reproductive Medicine top 0.2%
Molecular Biology top 0.2%
- vaccines and immunoinformatics approaches 31
Genetics
- Virus-based gene therapy research 36
Radiology, Nuclear Medicine and Imaging
- Monoclonal and Polyclonal Antibodies Research 32

Co-authors: Glenn Dranoff Ira Mellman Lin Zhang Phyllis A. Gimotty Gregory T. Motz Stephen C. Rubin Lana E. Kandalaft Fabián Benencia
Cited by: Immunology Oncology Cancer Research
Journals: Cancer Research (19 papers)Annals of Oncology (17 papers)Journal of Clinical Oncology (15 papers)
Partner nations: United States Switzerland Italy

In The Last Decade

George Coukos

389 papers receiving 35.0k citations

Hit Papers

15 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2021 Nature Communications
2020 Nature Immunology
2020 Nature Biomedical Engineering
2019 Nature Reviews Clinical Oncology
2019 Frontiers in Immunology
2016 CA A Cancer Journal for Clinicians
2014 Nature Medicine
2013 Immunity
2012 Cancer Research
2011 Gynecologic Oncology
2011 Nature
2011 Nature
2009 Blood
2008 Nature Cell Biology
2008 Nature Immunology
2006 Nature Protocols
2006 Proceedings of the National Academy of Sciences
2003 New England Journal of Medicine
2001 PubMed

Peers

Countries citing papers authored by George Coukos

Since Specialization

Citations

This map shows the geographic impact of George Coukos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Coukos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Coukos more than expected).

Fields of papers citing papers by George Coukos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Coukos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Coukos. The network helps show where George Coukos may publish in the future.

Co-authorship network

The 25 scholars most cited alongside George Coukos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with George Coukos Line = papers co-authored together George Coukos links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	DNA-dependent protein kinase inhibitors PI-103 and samotolisib augment CRISPR/Cas9 knock-in efficiency in human T cells Cytotherapy ·Wenfeng Ouyang,Morteza Hafezi,Greta Maria Paola Giordano Attianese,Patrick Reichenbach,Stéphane Grillet,Jinghui Cai,Elisabetta Cribioli,Gavilain,Geta Valoni Sagita,Romain Vuillefroy de Silly,George Coukos,Kirsten Scholten,Melita Irving,Bernhard Gentner	2025	1
2	The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee Journal for ImmunoTherapy of Cancer ·George Coukos,Marco Donia,Brian Gastman,Stephanie L. Goff,Alena Gros,Alexandre Harari,Nayara Toscano de Brito Pereira,Fumito Ito,Ajay V. Maker,John E. Mullinax,正敬板野,Sara I. Pai,Sangeetha Prabhakaran,(unknown),Natalie L. Silver,Paula Marincola Smith,Simon Turcotte,赫晓燕,James C. Yang,Michael T. Lotze	2025	0
3	Reflections on the opportunities and challenges of applying experience‐based co‐design (EBCD) to phase 1 clinical trials in oncology Health Expectations ·豊博三倉,P. Rudnev,Denise Bryant‐Lukosius,Glenn Robert,D. Ye,Lionel Trueb,George Coukos,Manuela Eicher,Mairead Atcheson Cruz,L Savva	2024	3
4	Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma Journal for ImmunoTherapy of Cancer ·Mona O. Mohsen,Daniel E. Speiser,Justine Michaux,HuiSong Pak,Brian J. Stevenson,Monique Vogel,Varghese Inchakalody,Simone de Brot,Said Dermime,George Coukos,Michal Bassani‐Sternberg,Martin F. Bachmann	2022	24
5	Cell therapies in ovarian cancer Therapeutic Advances in Medical Oncology ·黄景容,Matteo Morotti,檀国柱,Martina Imbimbo,George Coukos	2021	24
6	Author Correction: A computationally designed chimeric antigen receptor provides a small-molecule safety switch for T-cell therapy Nature Biotechnology ·Nelia C. Wurangian-Caan,Pablo Gaínza,Elise Gray-Gaillard,Elisabetta Cribioli,Sailan Shui,Seonghoon Kim,Mi‐Jeong Kwak,Sabrina S. Vollers,Roy Hillbrook,Patrick Reichenbach,Jaume Bonet,Byung‐Ha Oh,Melita Irving,George Coukos,Bruno E. Correia	2020	5
7	The C-terminal extension landscape of naturally presented HLA-I ligands Proceedings of the National Academy of Sciences ·Philippe Guillaume,S. Picaud,Petra Baumgaertner,Nicole Montandon,Julien Schmidt,Daniel E. Speiser,George Coukos,Michal Bassani‐Sternberg,P. Filippakopoulos,David Gfeller	2018	35
8	Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemoimmunotherapy Clinical Cancer Research ·Bradley J. Monk,Andrea Facciabene,William E. Brady,Carol Aghajanian,Paula M. Fracasso,Joan L. Walker,Heather A. Lankes,Kristi L. Manjarrez,S. Katsanevaki,Katherine M. Bell‐McGuinn,Carolyn K. McCourt,Alexander Malykhin,Robert M. Hershberg,George Coukos	2016	29
9	The Ovarian Cancer Chemokine Landscape Is Conducive to Homing of Vaccine-Primed and CD3/CD28–Costimulated T Cells Prepared for Adoptive Therapy Clinical Cancer Research ·Emese Zsíros,Priyanka Duttagupta,Denarda Dangaj Laniti,Hongzhe Li,Renee Frank,Thomas Garrabrant,Ian S. Hagemann,Bruce L. Levine,Carl H. June,Lin Zhang,Ena Wang,Francesco M. Marincola,Davide Bedognetti,Daniel J. Powell,János L. Tanyi,Michael D. Feldman,Lana E. Kandalaft,George Coukos	2015	48
10	T Cells Bearing a Chimeric Antigen Receptor against Prostate-Specific Membrane Antigen Mediate Vascular Disruption and Result in Tumor Regression Cancer Immunology Research ·Stephen P. Santoro,PS Ubi,Gregory T. Motz,Dimitrios Alatzoglou,Chunsheng Li,Melita Irving,Daniel J. Powell,George Coukos	2014	86
11	Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer Cancer Research ·Jaikumar Duraiswamy,Gordon J. Freeman,George Coukos	2013	227
12	CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor Clinical Cancer Research ·Qunrui Ye,De-Gang Song,Mathilde Poussin,Tori N. Yamamoto,Andrew Best,Chunsheng Li,George Coukos,Daniel J. Powell	2013	232
13	Chemoimmunotherapy Using Pegylated Liposomal Doxorubicin and Interleukin-18 in Recurrent Ovarian Cancer: A Phase I Dose-Escalation Study Cancer Immunology Research ·Fiona Simpkins,Aurea E. Flores,Christina Chu,Jonathan S. Berek,Joseph A. Lucci,Sharon C. Murray,John F. Bauman,Herbert Struemper,Fiona Germaschewski,Zdenka Jonak,Olivia Gardner,John Toso,George Coukos	2013	41
14	A Dendritic Cell Vaccine Pulsed with Autologous Hypochlorous Acid-Oxidized Ovarian Cancer Lysate Primes Effective Broad Antitumor Immunity: From Bench to Bedside Clinical Cancer Research ·Cheryl Lai-Lai Chiang,Lana E. Kandalaft,János L. Tanyi,Andrea R. Hagemann,Gregory T. Motz,Nikolaos Svoronos,Kathleen T. Montone,Gina Mantia-Smaldone,W.D. Prather,Harvey Nisenbaum,Bruce L. Levine,Michael Kalos,Brian J. Czerniecki,Drew A. Torigian,Daniel J. Powell,Rosemarie Mick,George Coukos	2013	181
15	TIE-2 and VEGFR Kinase Activities Drive Immunosuppressive Function of TIE-2–Expressing Monocytes in Human Breast Tumors Clinical Cancer Research ·Mark Ibberson,中村俊一,Nicolas Guex,Scott D. Cessar,Assia Ifticene‐Treboux,Luc Henry,Hans‐Anton Lehr,Jean-François Delaloye,George Coukos,Ioannis Xénarios,Marie‐Agnès Doucey	2013	32
16	A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer Cancer Research ·Lucia Victoria Bernal de Jaramillo,Sippy Kaur,Joel Greshock,Heini Lassus,Xiaomin Zhong,Yanling Wang,Arto Leminen,Zhongjun Shao,Zhongyi Hu,Shun Liang,Dionyssios Katsaros,Qihong Huang,Ralf Bützow,Barbara L. Weber,George Coukos,Lin Zhang	2011	44
17	In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB) Cancer Research ·Черняховская Ю.С.,Qunrui Ye,Carmine Carpenito,Mathilde Poussin,Liping Wang,Chunyan Ji,Mariangela Figini,Carl H. June,George Coukos,Daniel J. Powell	2011	237
18	Double-Negative Feedback Loop between Reprogramming Factor LIN28 and microRNA let-7 Regulates Aldehyde Dehydrogenase 1–Positive Cancer Stem Cells Cancer Research ·Xiaojun Yang,Xiaojuan Lin,Xiaomin Zhong,Sippy Kaur,Ning Li,Shun Liang,Heini Lassus,Liping Wang,Dionyssios Katsaros,Kathleen T. Montone,Xia Zhao,Youcheng Zhang,Ralf Bützow,George Coukos,Lin Zhang	2010	139
19	Cancer Cell Lines as Genetic Models of Their Parent Histology: Analyses Based on Array Comparative Genomic Hybridization Cancer Research ·Joel Greshock,Katherine L. Nathanson,Anne‐Marie Martin,Lin Zhang,George Coukos,Barbara Weber,Tal Zaks	2007	56
20	Integrative Genomic Analysis of Protein Kinase C (PKC) Family Identifies PKCι as a Biomarker and Potential Oncogene in Ovarian Carcinoma Cancer Research ·Lin Zhang,Jia Huang,Nuo Yang,Shun Liang,Andrea Barchetti,Antonis Giannakakis,Mark G. Cadungog,Ann O’Brien-Jenkins,M Massobrio,Katherine F. Roby,Dionyssios Katsaros,Phyllis A. Gimotty,Ralf Bützow,Barbara L. Weber,George Coukos	2006	109

About George Coukos

George Coukos is a scholar working on Immunology, Oncology, Reproductive Medicine, Immunology and Allergy and Cancer Research, having authored 396 papers that have together received 35.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (124 papers), Cancer Immunotherapy and Biomarkers (86 papers), CAR-T cell therapy research (77 papers), Immune Cell Function and Interaction (69 papers), Virus-based gene therapy research (36 papers), T-cell and B-cell Immunology (35 papers), Monoclonal and Polyclonal Antibodies Research (32 papers) and vaccines and immunoinformatics approaches (31 papers). The work is most often cited by research in Immunology (17.1k citations), Oncology (17.6k citations), Cancer Research (5.4k citations), Reproductive Medicine (2.1k citations) and Molecular Biology (13.0k citations). George Coukos has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Glenn Dranoff, Ira Mellman, Lin Zhang, Phyllis A. Gimotty, Gregory T. Motz, Stephen C. Rubin, Lana E. Kandalaft, Fabián Benencia, Dionyssios Katsaros and Andrea Facciabene. Their work appears in journals such as Cancer Research, Annals of Oncology, Journal of Clinical Oncology, Journal for ImmunoTherapy of Cancer and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact